These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7686808)

  • 1. COP-BLAM multidrug infusion chemotherapies for lymphoma: results in a community hospital setting.
    Topilow AA; Guerra OR; Tarantolo SR; Lerner WA; Snyder GC
    Cancer Invest; 1993; 11(4):371-8. PubMed ID: 7686808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N; Hara A; Kaneko H; Umeda M; Shirai T
    Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
    Coleman M; Armitage JO; Gaynor M; McDermott D; Weisenburger DD; Adler K; Beshevkin M; Silver RT; Reisman AM; Pasmantier MW
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
    Niitsu N; Umeda M; Shirai T
    Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):753-8. PubMed ID: 7693992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COP-BLAM therapy for a Hodgkin's disease in the elderly].
    Niitsu N; Nakayama M; Umeda M
    Nihon Ronen Igakkai Zasshi; 1999 Jun; 36(6):412-5. PubMed ID: 10513213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N; Hara A; Kaneko H; Shirai T
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):357-62. PubMed ID: 1699013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
    Arai N; Hara A; Umeda M; Shirai T
    Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.
    Laurence J; Coleman M; Allen SL; Silver RT; Pasmantier M
    Ann Intern Med; 1982 Aug; 97(2):190-5. PubMed ID: 6179448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
    Niitsu N; Umeda M
    Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CODBLAM IV chemotherapy for large cell lymphoma: sequential use of infusional vincristine and bleomycin and "high dose" consolidation.
    Rafi S; Coleman M; Kaufmann T; Cesarman G; Papish SW; Bernhart B; Gaynor M; Reisman AM
    Am J Clin Oncol; 1997 Feb; 20(1):90-6. PubMed ID: 9020298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM.
    Niitsu N; Umeda M
    Eur J Haematol; 1999 Nov; 63(5):337-44. PubMed ID: 10580566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
    Engelhard M; Meusers P; Brittinger G; Brack N; Dornoff W; Enne W; Gassmann W; Gerhartz H; Hallek M; Heise J
    Ann Oncol; 1991 Feb; 2 Suppl 2():177-80. PubMed ID: 1710919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
    Niitsu N; Umeda M
    Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
    Niitsu N; Umeda M
    Eur J Haematol; 1996 Mar; 56(3):163-7. PubMed ID: 8598236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1995 Feb; 36(2):84-90. PubMed ID: 7536279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Kreissl S; Sökler M; Hellmuth JC; Meissner J; Mathas S; Topp MS; Behringer K; Klapper W; Kuhnert G; Dietlein M; Kobe C; Fuchs M; Diehl V; Engert A; Borchmann P
    Lancet Oncol; 2017 Dec; 18(12):1680-1687. PubMed ID: 29133014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
    Engelhard M; Gerhartz H; Brittinger G; Engert A; Fuchs R; Geiseler B; Gerhartz D; Haunauske AR; Hartlapp HJ; Huhn D
    Ann Oncol; 1994; 5 Suppl 2():123-5. PubMed ID: 7515644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.